Osteosarcoma: Lessons Learned and Future Avenues

by Ajay Puri, Norman Jaffe, Hans Gelderblom
Published 2013-01-01

Osteosarcoma: Evolution of Treatment Paradigms

by Norman Jaffe, Ajay Puri, Hans Gelderblom
Published 2013-01-01

Automated gathering of real-world data from online patient forums can complement pharmacovigilance for rare cancers

by Anne Dirkson, Suzan Verberne, Wessel Kraaij, Gerard van Oortmerssen, Hans Gelderblom
Published 2022-06-01

Evaluation of Quality of Life at Progression in Patients with Soft Tissue Sarcoma

by Stacie Hudgens, Anna Forsythe, Ilias Kontoudis, David D’Adamo, Ashley Bird, Hans Gelderblom
Published 2017-01-01

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma

by Stefanie de Groot, Bas Röttgering, Hans Gelderblom, Hanno Pijl, Karoly Szuhai, Judith R. Kroep
Published 2020-11-01

Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.

by Jara Baas, Lisanne Krens, Stefan Bohringer, Linda Mol, Cornelis Punt, Henk-Jan Guchelaar, Hans Gelderblom
Published 2018-01-01

Bevacizumab Treatment for Patients with <i>NF2</i>-Related Schwannomatosis: A Single Center Experience

by Jules P. J. Douwes, Erik F. Hensen, Jeroen C. Jansen, Hans Gelderblom, Josefine E. Schopman
Published 2024-04-01

Treatment Strategies for Metastatic Soft Tissue Sarcomas

by Lisette M. Wiltink, Rick L. M. Haas, Hans Gelderblom, Michiel A. J. van de Sande
Published 2021-04-01

Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases

by Monique J. L. Mastboom, Floortje G. M. Verspoor, Hans Gelderblom, Michiel A. J. van de Sande
Published 2017-01-01

A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report

by Arie J. Verschoor, Fabiënne A. R. M. Warmerdam, Tjalling Bosse, Judith V. M. G. Bovée, Hans Gelderblom
Published 2018-01-01

Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Co...

by Jan Pander, Lieke van Huis-Tanja, Stefan Böhringer, Tahar van der Straaten, Hans Gelderblom, Cornelis Punt, Henk-Jan Guchelaar
Published 2015-01-01

Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000–2017 Netherlands Cancer Registry Database Analysis...

by Milan Van Meekeren, Marta Fiocco, Vincent K. Y. Ho, Judith V. M. G. Bovée, Hans Gelderblom, Rick L. Haas
Published 2021-01-01

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer

by Cor J. Ravensbergen, Meaghan Polack, Jessica Roelands, Stijn Crobach, Hein Putter, Hans Gelderblom, Rob A. E. M. Tollenaar, Wilma E. Mesker
Published 2021-10-01

MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment

by Geert Spierenburg, Carlos Suevos Ballesteros, Berend C. Stoel, Ana Navas Cañete, Hans Gelderblom, Michiel A. J. van de Sande, Kirsten van Langevelde
Published 2023-02-01

Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study.

by Lisanne L Krens, Lieke H J Simkens, Jara M Baas, Els R Koomen, Hans Gelderblom, Cornelis J A Punt, Henk-Jan Guchelaar
Published 2014-01-01

Translating pharmacogenomics: challenges on the road to the clinic.

by Jesse J Swen, Tom W Huizinga, Hans Gelderblom, Elisabeth G E de Vries, Willem J J Assendelft, Julia Kirchheiner, Henk-Jan Guchelaar
Published 2007-08-01

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer

by Cor J. Ravensbergen, Matthew Kuruc, Meaghan Polack, Stijn Crobach, Hein Putter, Hans Gelderblom, Devjit Roy, Rob A. E. M. Tollenaar, Wilma E. Mesker
Published 2021-12-01

Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study

by Arie J Verschoor, Judith V M G Bovée, Monique J L Mastboom, P D Sander Dijkstra, Michiel A J Van De Sande, Hans Gelderblom
Published 2018-09-01

Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma

by Ieva Palubeckaitė, Sanne Venneker, Inge H. Briaire-de Bruijn, Brendy E. van den Akker, Augustinus D. Krol, Hans Gelderblom, Judith V. M. G. Bovée
Published 2020-12-01

Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study

by Peter Reichardt, Michael Leahy, Xavier Garcia del Muro, Stefano Ferrari, Javier Martin, Hans Gelderblom, Jingshu Wang, Arun Krishna, Jennifer Eriksson, Arthur Staddon, Jean-Yves Blay
Published 2012-01-01